There is increasing concern worldwide at the steady growth in acute inpatient admissions and emergency department (ED) attendances.
Introduction
There is worldwide concern at the cost and sustainability of growth in unplanned use of hospitals from both acute inpatient admissions and emergency department (ED) attendance. 1, 2 Assuming a significant portion of this is avoidable, it represents wasteful use of scarce health resources and is potentially damaging to population health. 3 Growth in unplanned hospital use poses a particularly serious problem for district health boards (DHBs) that are struggling to respond to an increasingly constrained fiscal environment. Based on current national prices, each percentage increase in the age-standardised rate of acute admissions currently costs the country's DHBs $38 million, excluding the additional impact of population growth and ageing. Avoidable hospitalisation may lead to unnecessary medical intervention and complications, such as falls and nosocomial infection. Reducing avoidable hospitalisation is therefore desirable from a population health, as well as an economic, perspective.
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ORIGINAL SCIENTIFIC PAPER At Waitemata DHB, in the 10 years from 2003 to 2012, the annual ED attendance rate doubled from 92 to 187 per 1000, while the rate of acute admissions rose 44% from 41 to 59 per 1000 (Figure 1) . However, the rate of general practitioner (GP)-referred acute admissions declined, with the proportion dropping from 49% to 29%. Over that time, the proportion of self-referred patients (those presenting directly to hospital) increased substantially.
We also know that there is substantial variation between general practices in their patients' ED attendance and acute admission rates that cannot be explained by demographic factors (age, gender, deprivation, ethnicity etc). 4, 5 Part of this variation appears to be attributable to differences in access to primary care. [6] [7] [8] Good continuity of care has been associated with less ambulatory-sensitive hospitalisation (ASH), 9 and after-hours general practice services may reduce unplanned admissions for minor illnesses in children; 10 however, one study concluded that increasing access to primary care did not reduce the rate of acute hospitalisation. 11 The quality of primary care (e.g. physician experience and adherence to clinical guidelines) may also explain some of the variation in acute hospital use [12] [13] [14] and hospital care costs. 15 Efforts to better understand primary care factors that explain variation in the rate of acute hospital use using ASH or avoidable hospitalisation have generally failed to account for sociodemographic differences in general practice-enrolled populations. This paper reports the development of two novel measures that do account for these sociodemographic differences. These are the standardised acute hospital admission ratio (SAAR) and the standardised ED attendance ratio (SEAR).
We hypothesised that variation between practices in these indicators reflects practice-level differences in two key factors: access to primary care, and the effectiveness of primary care management of patients with long-term conditions. If true, then we would expect SAARs to be relatively stable within a practice over time, and that practices with high SAARs for one disease/ patient group will be more likely to have high SAARs for others.
We also explored two alternative explanations for practice variation in SAAR:
1. that practices have high SAARs because they have a greater proportion of patients with complex conditions and comorbidities that might predispose them to acute admission (the disease-loading hypothesis); and 2. that patients who live close to an acute hospital make greater use of the hospital ED and consequently have a higher acute admission rate.
Methods

Population and data sources
The population studied was composed of the enrolled population of all general practices in New Zealand's northern region (Northland, Waitemata, Auckland and Counties Manukau DHBs) primary health organisations (PHOs). The data extract for the first calendar quarter of the year was used to define this population and two
WHAT GAP THIS FILLS
What we already know: There is unexplained variation in unplanned use of hospitals, including acute inpatient admission and emergency department (ED) attendance in New Zealand.
What this study adds:
This work has developed robust measures of unplanned hospital use and demonstrated that the observed high level of practice variation is not due to differences in the clinical complexity of practice populations.
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ORIGINAL SCIENTIFIC PAPER financial years were studied (1 July to 30 June 2009/10 and 2010/11).
Neonates, people domiciled overseas, and individuals with missing demographic data were excluded. The three data sources used in this study were the PHO registers (for the population denominator), the National Minimum Dataset (for acute hospital admissions) and the National Non-admitted Patients Collection (NNPAC), for ED and outpatient attendances. Patients from the PHO register were linked to hospital admissions and ED attendances using encrypted National Health Index (NHI) numbers. Data was analysed for two financial years. Only practices with data for both financial years are presented in this study's analysis (of which there were 364 for the SEAR and 367 for the SAAR indicator). The geographic characteristics of the population (urban versus rural etc.) were determined by matching Statistics New Zealand data to census meshblocks.
Measures of practice variation in acute hospital use
The SAAR and SEAR measures we developed use indirect standardisation to control for the demographic composition of each practice in terms of sex, age, ethnicity and deprivation as recorded in the PHO register (see the Appendix in the web version of this paper for further details on how the SAAR and SEAR measures were calculated). Disease-or condition-specific SAAR rates are defined by the International Classification of Diseases version 10 (ICD-10) codes or Diagnosis Related Groups (DRGs). The DRGs identify the overall clinical 'product' that patients receive from their hospital stay and form the basis for costing that event. The categories were:
• 'all acute' (with length of stay ≥1 day)
• cellulitis • asthma • chronic obstructive pulmonary disease (COPD) and bronchiectasis • constipation • oesophagitis, gastroenteritis and miscellaneous gastrointestinal disorders • congestive heart failure (CHF), and • diabetes.
The specific codes defining each condition are listed in Table A1 in the Appendix for further details.
Assessment of reliability and validity of the SAAR
The Pearson correlation coefficient was used to test for correlations between SAAR/SEAR measures for the different disease/patient groups and for correlations between 2009/10 and 2010/11. To test the disease-loading hypothesis, we examined three measures of the average clinical complexity of practices' acute hospital admissions: costweight; patient clinical complexity level (PCCL) and the Charlson comorbidity index 16 (CCI). Cost-weight is an indication of the cost of the admission, based on a set figure for each DRG code. The PCCL is a measure of the cumulative effect of a patient's complications and comorbidities. 17 The calculation is complex and is designed to prevent similar conditions being counted more than once. Since the practice population itself would give rise to differences in the clinical complexity of acute admissions (e.g. practices with older patients might have more complex admissions), the three complexity measures were (indirectly) standardised to total northern region population to produce a standardised cost-weight ratio, a standardised PCCL ratio, and a standardised Charlson comorbidity ratio.
For ED attendance and total acute admissions, practices were divided into those with a SAAR/ SEAR of 1.1 or higher ('high'), those 0.9 or lower ('low') and those in between ('normal'). Analysis of variance tested for a linear trend in the standardised ratios for cost-weight, PCCL and CCI, across low, normal and high SAAR practices.
To see whether patients living closer to a 24-hour ED had a higher acute admission rate, we calculated median travelling times for each practice population. This was done by ranking the travelling times to hospital from the population centroid of all census meshblocks resided in by the practice's patient population, and using this to identify the meshblock of the median patient travelling time.
The PHO Performance Programme (PPP) data for three indicators were used to determine whether SAAR indicators are related to independent measures of practice performance. The PPP indicators are measured quarterly, but they are not standardised by any variable. For the cervical screening and influenza vaccination indicators, only practices with complete data for August 2009 to July 2011 were included. For immunisation at two years, data from the period November 2010 to July 2011 were available for comparison with SAAR data for 2010/11. Practices that changed PHOs in the course of a quarter were excluded.
Health and Disability Ethics Committee Review was not required as this study was a minimal risk observational study that presents no individual identifying data.
Results
The total population in the New Zealand northern region PHO register was 1 538 032 in 2009/10 and 1 562 058 in 2010/11. A detailed breakdown of the study population by age, gender, ethnicity and socioeconomic deprivation is provided in the Appendix in the web version of this paper (Table A2 ).
There were predictable differences between DHBs in the ethnic, geographic and socioeconomic composition of their practices (see Table  A3 in the Appendix for details). There were also differences between the DHBs in the proportion of practices using the 'Very Low Cost Access' funding formula. Practice characteristics remained relatively constant over the two years. Figure 2 illustrates the distribution of 'all acute' SAARs for 367 practices in a funnel plot. Practices with SAARs above and below 100 have, respectively, higher and lower acute admissions with a SAAR of 100 is equal to the number of expected events SEAR Standardised emergency department attendance ratio NNPAC National non-admitted patients collection PHO Primary health organisation * The ratios in this figure are multiplied by 100. Hence, the number of observed events in a practice with a SAAR of 100 is equal to the number of expected events than the expected rate given the composition of their population. Note that a significant number of practices fall both above and below the 3 standard deviation (SD) limits, suggesting high practice variation in admission rates that cannot be explained by random variation nor differences in the practice demographic characteristics.
There was a statistically significant correlation in practices' SAAR and SEAR between 2009/10 and 2010/11 for all indicators except constipation (see Appendix Table A4 for details), demonstrating that practices with high rates in one year were likely to have high rates the following year. The highest inter-year correlation coefficients were for all acute admissions and for total (non-accident) ED attendances. In Table 2 , we explore whether the SAAR simply reflects the mix of patients within a practice, such that high SAAR practices have more complex patients and patients with higher comorbidities than low SAAR practices. The results do not support this hypothesis. The standardised CCI and PCCL ratios are not significantly related to either the all-acute SAAR or the SEAR. The cost-weight of admissions is significantly related to both of these ratios, but not in the expected manner. Rather, high SAAR practices are associ- 
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ated with lower cost admissions, suggesting that these are of a lower complexity.
As shown in Table 3 , only total ED attendances, total acute admissions, cellulitis and CHF were significantly related to travelling time to an ED. Even for these, it is clear from the table that the travelling time to an ED only differs between low and normal SAAR practices but not between normal and high SAAR practices. The size of practices' enrolled populations was not significantly correlated with SEAR or any of the SAAR variables (results not shown).
There was no significant association between any SAAR indicator and practices' influenza or undertwo immunisation coverage. However, cervical screening was significantly associated with the ED attendance and all acute admissions SAARs, as well as with the COPD SAAR, such that practices with higher SAAR tended to have lower coverage rates. The detail on these relationships between PPP indicators and SAARs is presented in the Appendix (Table A5) in the web version of this paper.
Discussion
The main purpose of this analysis was not to make performance assessments of individual practices, but to determine how well practice variation in acute hospital use can be measured using the SAAR and SEAR indicators. Using routinely collected data, it was possible to compare almost 400 practices serving a combined population of over 1.5 million people, for two consecutive years. The study population was ethnically, socioeconomically and geographically diverse, varied considerably in access to 24-hour emergency care, and was served by hospitals ranging from small rural hospitals (e.g. Kawakawa) to the tertiarylevel Auckland City Hospital.
The results have shown that, overall, practices whose population made high use of acute hospital care in one year were more likely to do so in the following year. This gives an indication of the reliability of the SAAR indicators. The strongest inter-year correlations were observed for the all acute and ED attendance measures, which were also the ones with the highest numbers of events, and hence the least prone to random variation. 
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Patients from practices with lower access to, or quality of, care might be expected to make high acute use of hospitals for more than just one condition. This is exactly what Table A5 shows. Differences in access are especially likely to create high SAAR correlations between conditions. However, not all of the SAAR indicators were strongly correlated with one another. Cellulitis and constipation were poorly correlated with each other, but each was significantly correlated with most of the other SAAR indicators. This might be because they are influenced by different aspects of primary care: cellulitis perhaps being more affected by access, while a high constipation admission rate could be more indicative of the quality of clinical diagnosis and management (constipation typically presenting as abdominal pain).
The finding that admitted patients in practices with high SAAR/SEAR have no more comorbidities or clinical complications than those in low SAAR/SEAR practices, and actually have lower average treatment costs, rules out the possibility that the observed practice variation in SAAR is due to practice population differences in clinical need. This is not to deny that some practices may have more complex patients and, as a result, a higher SAAR.
As demonstrated by other researchers, 18 travelling time to a 24-hour ED explains some of the practice variation in SAAR and SEAR. However, this appears to be important only for the difference between the low SAAR group and the medium/high SAAR group. It would be prudent to control for this factor in future analyses.
Other non-practice-specific factors will also account for some variation in SAAR and SEAR. For example, practices served by a hospital with short ED waiting times may have higher SAAR and SEAR than those served by a hospital with long waiting times. Future analyses might attempt to control for hospital-specific and DHBspecific factors. However, rather than to attempt to identify all non-practice sources of inter-practice variation in unplanned hospital use, our aim was to identify those factors operating at practice level that explain this variation, with a particular focus on those that might be subject to modification through some sort of intervention.
Limitations
Firstly, it is important to note that the statistical nature of standardised ratios precludes pairwise comparisons between practices, and we have not attempted to do this. The study has relied upon PHO register data for patient demographics. Unfortunately, it is known that ethnicity is often poorly recorded in primary care 19, 20 and this may have limited the extent to which standardisation was able to control for ethnic differences in hospital usage.
The SAAR and SEAR were significantly but quite weakly linked to cervical screening coverage by practices, and not related at all to the other two practice 'performance' indicators. However, the PPP data was not standardised and hence may not serve as a valid comparator for this study. The link with cervical screening could be interpreted in the light of access to care, given the financial barrier that still exists for most patients to this service. Child immunisation and influenza immunisation are both free services. It is unfortunate that the PPP does not provide practice-level data on a broader range of measures against which to test for associations with SAAR and SEAR.
The findings provide some guidance as to how the SEAR/SAAR measures might be improved. Outlier practices serving a population with a clearly different level of risk of hospital use beyond that captured by the variables used in standardisation should be identified and excluded. Standardisation should incorporate some measure of travelling time to a 24-hour ED.
There may be differences in the characteristics of the practice population beyond those accounted for in standardising by ethnicity, deprivation, age and sex. For example, practices with particularly high proportions of transient or mentally ill patients, or of patients in aged residential care facilities, might be expected to have different SAARs from the typical general practice. Similarly, standardising for ethnicity with the broad category of 'Asian' may not capture important difference in the utilisation of hospitals by Indians compared with Chinese or Korean, giving rise to residual confounding. More sophisticated modelling techniques and more detailed practice population data may be needed to ensure valid comparison at the level of individual practices.
In conclusion, the work confirms international findings that there is substantial unexplained variation in patient hospital use among general practice patient populations. The study has also highlighted the lack of a broad range of primary care performance measures against which to assess the SAAR and SEAR measures. If specific structural and/or organisational features of practices with high and low SAARs could be identified in future research, there may be considerable scope to improve population health at the primary care level and, in doing so, to reduce unnecessary or avoidable hospitalisations, along with their associated costs.
QUANTITATIVE RESEARCH: APPENDIX ORIGINAL SCIENTIFIC PAPERS APPENDIX 1
Calculation of the SAAR and SEAR measures
The SAAR and SEAR measures are ratios of the observed to the expected number of admissions (or ED attendances), given the demographic composition of the practice. There were 10 age strata, 4 ethnic strata and 4 deprivation strata making a total of 320 (including gender). Patients with unstated ethnicity were classified as European/ Other. Deprivation was grouped as quintiles 1-3, quintile 4, quintile 5 and not stated. The age strata used were those shown in Table 1 .
Confidence limits for the standardised acute admission/attendance ratios were calculated using the Sahai and Khursid exact method as follows: 
